Where does AbbVie make most of its revenue?

United States: 76% of revenue by region in fiscal year 2025, followed by ALL Other Countries (9%).

What companies are similar to AbbVie?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Johnson & Johnson (JNJ), Novartis AG (NVS), AstraZeneca PLC (AZN), Amgen Inc. (AMGN).

AbbVie Inc. (ABBV) Stock

Executive TeamFinancialsLayoffsShareholders

About AbbVie Inc.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various ca...

At a glance

In Q2 2026 (the quarter ended June 30, 2026) revenue was $16.99 billion, up 10.2% from a year before. United States was its largest region in fiscal year 2025, with 76% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.